Señales en vivo de GBLX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 15:08):

Stats
Volumen de hoy	81 311.00
Volumen promedio	123 712
Capitalización de mercado	2.72M
EPS	$0 ( 2024-02-02 )
Próxima fecha de ganancias	( $0 ) 2024-07-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.670
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2018-07-11	Poss John C	Buy	3 615	Common Stock
2018-07-11	Poss John C	Buy	11 915	Common Stock
2018-07-11	Poss John C	Buy	20 000	Common Stock
2018-07-11	Poss John C	Buy	1 250	Common Stock
2018-07-11	Poss John C	Buy	30 000	Common Stock

INSIDER POWER
0.00
Last 84 transactions
Buy: 3 790 243 \| Sell: 13 501 701

GB Sciences, Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

GB Sciences, Inc. Finanzas

Annual	2022
Ingresos:	$0
Beneficio Bruto:	$-61 660.00 (0.00 %)
EPS:	$-7 356.48

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-61 660.00 (0.00 %)
EPS:	$-7 356.48

FY	2022
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$0.00520

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.0133

Financial Reports:

No articles found.

GB Sciences, Inc.

GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.